Your newspaper correctly reported that according to the Institute of Medicine's panel of experts, “numerous safety-related issues over the past few years … have led to a lack of confidence in drug development and regulation” (“IOM Report Calls for Change in Emphasis at FDA,” October 2006, p. 26).